Performance
Day's Low
Day's High
₹93.25₹96.152 Week's Low
52 Week's High
₹31.3₹100.9
| Returns % | |
| 1 Month Return | + 59.75 % |
| 3 Month Return | + 66.84 % |
| 1 Year Return | + 150.01 % |
| Market Stats | |
| Previous Close | ₹94.04 |
| Open | ₹94.42 |
| Volume | 1.04Cr |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹5,152.96Cr |
Key Statistics
| P/E Ratio | 40.71 |
| PEG Ratio | 29.71 |
| Market Cap | ₹5,152.96 Cr |
| P/B Ratio | 2.42 |
| EPS | 1.89 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 13.29 |
Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹5,152.96 Cr | 82.61% | 0.53 | ₹96 Cr | ₹1,690 Cr | |
| HOLD | ₹28,529.52 Cr | 36.21% | 0.53 | ₹1,388 Cr | ₹3,998 Cr | |
| NA | ₹201.49 Cr | 107.8% | 0.75 | NA | NA | |
| NA | ₹1,089.43 Cr | 35.92% | 0.51 | NA | NA | |
| NA | ₹853.21 Cr | 43.43% | 0.78 | ₹47 Cr | ₹1,207 Cr |
Company Information
Share Price: ₹93.63 per share as on 13 Sep, 2024 04:01 PM
Market Capitalisation: ₹5,152.96Cr as of today
Revenue: ₹455.22Cr as on June 2024 (Q2 24)
Net Profit: ₹36.17Cr as on June 2024 (Q2 24)
Listing date: 15 May, 1995
Chairperson Name: Sushil Suri
| Organisation | Morepen Laboratories Ltd |
| Headquarters | Gurgaon |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Morepen Laboratories Ltd
Morepen Labs Shares Surge to New Highs - 04 Sep, 2024
Morepen Laboratories Ltd shares soared 12.45% to a 52-week high of Rs 92.43, driven by a 56% rally in a month following a successful QIP. Major investors like Bank of America and Samsung participated, boosting optimism in the healthcare devices sector. The stock is currently overbought, with technical resistance at Rs 92.5 and support at Rs 86.
Morepen Labs Achieves Record High Amid Strong Earnings - 22 Aug, 2024
Morepen Laboratories reported a 13.51% increase in net sales and a 147% rise in PAT for Q1 FY25. The stock surged to a 52-week high, reflecting strong performance and investor confidence.
Morepen Laboratories Projects Growth in Medical Devices - 13 Aug, 2024
Sushil Suri, CMD of Morepen Laboratories, anticipates that medical devices will grow to 40-45% of total sales in three years, up from 30% currently. The company's market capitalization stands at Rs 3,243.89 crore.
Morepen Labs Reports Strong Q1 Performance - 12 Aug, 2024
Morepen Laboratories' stock surged following a strong Q1 FY25 report, showing a 147% increase in net profit and a successful Rs 200 crore QIP. The medical devices segment grew by 20%, indicating robust growth potential.
Morepen Laboratories Raises Rs 200 Crore via QIP - 07 Aug, 2024
Morepen Laboratories successfully raised Rs 200 crore through a Qualified Institutional Placement, oversubscribed 1.68 times, with strong institutional backing. The funds will enhance growth and manufacturing capabilities.
Morepen Laboratories Sees Growth After QIP Success - 06 Aug, 2024
Morepen Laboratories Limited raised Rs. 200 Crores through a successful Qualified Institutional Placement, subscribed 1.68 times. Revenue grew 16.33% YoY, with profits increasing from Rs. 8 Crores to Rs. 29 Crores. The company reported a strong ROE of 12% and a low debt-to-equity ratio of 0.03.
Insights on Morepen Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, 28.28 Cr → 36.17 Cr (in ₹), with an average increase of 21.8% per quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, MOREPENLAB has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Price Rise
In the last 1 month, MOREPENLAB stock has moved up by 59.8%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 427.32 Cr → 458.64 Cr (in ₹), with an average increase of 6.8% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 1.67% to 7.72% in Aug 2024 quarter
NO EFFECTAgainst Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 137.2% return, outperforming this stock by 82.9%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 57.95% to 53.72% in Aug 2024 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 38.22% to 35.65% in Aug 2024 quarter
Company Financials
Index Inclusions
Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 35.65% | ||
| Foreign Institutions | 7.72% | 362.57 | |
| Mutual Funds | 0% | ||
| Retail Investors | 53.72% | ||
| Others | 2.91% | 34.83 |
Key Indicators
Morepen Laboratories Ltd Valuation
Morepen Laboratories Ltd in the last 5 years
Lowest (10.48x)
March 23, 2020
Today (40.71x)
September 13, 2024
Industry (58.76x)
September 13, 2024
Highest (64.70x)
January 22, 2018
Earnings and Dividends
Morepen Laboratories Ltd Earnings Results
Morepen Laboratories Ltd’s net profit jumped 147.23% since last year same period to ₹36.17Cr in the Q1 2024-2025. On a quarterly growth basis, Morepen Laboratories Ltd has generated 27.9% jump in its net profits since last 3-months.
Read More about Earnings Results
Technicals Summary
Bearish
Neutral
Bullish
Morepen Laboratories Ltd is currently in a Bullish trading position according to technical analysis indicators.
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Morepen Laboratories Ltd shares.
Morepen Laboratories Ltd (MOREPENLAB) share price today is ₹93.63
Morepen Laboratories Ltd is listed on NSE
Morepen Laboratories Ltd is listed on BSE
- Today’s highest price of Morepen Laboratories Ltd is ₹96.1.
- Today’s lowest price of Morepen Laboratories Ltd is ₹93.25.
PE Ratio of Morepen Laboratories Ltd is 40.71
PE ratio = Morepen Laboratories Ltd Market price per share / Morepen Laboratories Ltd Earnings per share
Today’s traded volume of Morepen Laboratories Ltd(MOREPENLAB) is 1.04Cr.
Today’s market capitalisation of Morepen Laboratories Ltd(MOREPENLAB) is ₹5152.96Cr.
| Morepen Laboratories Ltd(MOREPENLAB | Price |
|---|---|
52 Week High | ₹100.9 |
52 Week Low | ₹31.3 |
Morepen Laboratories Ltd(MOREPENLAB) share price is ₹93.63. It is down -7.21% from its 52 Week High price of ₹100.9
Morepen Laboratories Ltd(MOREPENLAB) share price is ₹93.63. It is up 199.14% from its 52 Week Low price of ₹31.3
| Morepen Laboratories Ltd(MOREPENLAB | Returns |
|---|---|
1 Day Returns | -0.41% |
1 Month Returns | 59.75% |
3 Month Returns | 66.84% |
1 Year Returns | 150.01% |